Increased Risk of Dementia in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study

被引:22
作者
Lin, Yu-Ru [1 ]
Chou, Lin-Chuan [1 ]
Chen, Hung-Chou [1 ,2 ]
Liou, Tsan-Hon [3 ,4 ]
Huang, Shih-Wei [1 ,2 ]
Lin, Hui-Wen [5 ,6 ]
机构
[1] Taipei Med Univ, Shuang Ho Hosp, Taipei, Taiwan
[2] Taipei Med Univ, Coll Med, Taipei, Taiwan
[3] Taipei Med Univ, Shuang Ho Hosp, Coll Med, Taipei, Taiwan
[4] Taipei Med Univ, Grad Inst Injury Prevent, Taipei, Taiwan
[5] Soochow Univ, Taipei, Taiwan
[6] Taipei Med Univ, Evidence Based Med Ctr, Wan Fang Hosp, Taipei, Taiwan
关键词
COGNITIVE IMPAIRMENT; ANTIBODIES; MEMORY; MOOD; GLUCOCORTICOIDS; NEUROTOXICITY; HIPPOCAMPUS; MECHANISMS; DIAGNOSIS; DISEASE;
D O I
10.1002/acr.22914
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Objective. Systemic lupus erythematosus (SLE) is a systemic autoimmune disorder characterized by varied clinical symptoms and can be comorbid with neuropsychiatric disorders. However, the association between SLE and dementia risk in patients with SLE remains unclear. In this study, we evaluated the incidence of dementia in patients with SLE. Methods. Patients were recruited from a nationwide cohort in 2004-2008 and categorized as SLE (n=1,074; patients diagnosed with SLE) or non-SLE (n=5,370; age-and sex-matched controls). Each patient was followed for up to 7 years, until either receiving a diagnosis of dementia or until December 31, 2010. Data were analyzed using the Kaplan-Meier method and Cox regression analysis. Results. The incidence rate of dementia was higher in the SLE cohort (357 per 100,000 person-years) than in the non-SLE cohort (180 per 100,000 person-years). Patients with SLE had a higher risk of dementia than did those without SLE (crude hazard ratio [HR] 1.92; P<0.05). Cox regression analysis revealed an adjusted HR for dementia in the SLE cohort of 2.14 (P<0.001), after adjustment for other comorbid diseases and variables. Conclusion. Patients with SLE have a higher risk of dementia.
引用
收藏
页码:1774 / 1779
页数:6
相关论文
共 35 条
[1]
Steroid and nonsteroidal anti-inflammatory drugs, cognitive decline, and dementia [J].
Ancelin, Marie-Laure ;
Carriere, Isabelle ;
Helmer, Catherine ;
Rouaud, Olivier ;
Pasquier, Florence ;
Berr, Claudine ;
Chaudieu, Isabelle ;
Ritchie, Karen .
NEUROBIOLOGY OF AGING, 2012, 33 (09) :2082-2090
[2]
Lesions of the human amygdala impair enhanced perception of emotionally salient events [J].
Anderson, AK ;
Phelps, EA .
NATURE, 2001, 411 (6835) :305-309
[3]
[Anonymous], WORLD ALZH REP 2009
[4]
Cerebral and corpus callosum atrophy in systemic lupus erythematosus [J].
Appenzeller, S ;
Rondina, JM ;
Li, LM ;
Costallat, LTL ;
Cendes, F .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2783-2789
[5]
Longitudinal analysis of gray and white matter loss in patients with systemic lupus erythematosus [J].
Appenzeller, Simone ;
Bonilha, Leonardo ;
Rio, Pablo A. ;
Li, Li Min ;
Lavras Costallat, Lilan Tereza ;
Cendes, Fernando .
NEUROIMAGE, 2007, 34 (02) :694-701
[6]
Cognitive Impairment and Employment Status in Systemic Lupus Erythematosus: A Prospective Longitudinal Study [J].
Appenzeller, Simone ;
Cendes, Fernando ;
Costallat, Lilian T. L. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (05) :680-687
[7]
Antiphospholipid antibodies in the acute phase of cerebral ischaemia in young adults: A descriptive study of 139 patients [J].
Blohorn, A ;
Guegan-Massardier, E ;
Triquenot, A ;
Onnient, Y ;
Tron, F ;
Borg, JY ;
Mihout, B .
CEREBROVASCULAR DISEASES, 2002, 13 (03) :156-162
[8]
Effects of Glucocorticoids on Mood, Memory, and the Hippocampus Treatment and Preventive Therapy [J].
Brown, E. Sherwood .
GLUCOCORTICOIDS AND MOOD CLINICAL MANIFESTATIONS, RISK FACTORS, AND MOLECULAR MECHANISMS, 2009, 1179 :41-55
[9]
Neuropsychiatric manifestations of systemic lupus erythematosus [J].
Bruns, Alessandra ;
Meyer, Olivier .
JOINT BONE SPINE, 2006, 73 (06) :639-645
[10]
CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.neuro.13.1.171